Autoreactive CD4 T cells in healthy mice
健康小鼠的自身反应性 CD4 T 细胞
基本信息
- 批准号:10170262
- 负责人:
- 金额:$ 38.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAgonistAntigen ReceptorsAntigen-Presenting CellsAutoantigensAutoimmune DiseasesAutoimmunityBar CodesBypassCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCellsChromatinDevelopmentDevicesDiphtheria ToxinDisabled PersonsEpigenetic ProcessGene TargetingGenomicsHomeostasisHumanImmune responseIndividualInfectionLeadMHC Class I GenesMHC Class II GenesMaintenanceMalignant NeoplasmsMicrofluidicsModelingMusOrganPathogenicityPeptidesPeripheralProtocols documentationReceptor CellRegulatory T-LymphocyteResearchRestRoleSelf ToleranceSpecificityStromal CellsSystemT-LymphocyteT-Lymphocyte SubsetsTCR ActivationTestingTherapeuticThymus GlandTissuesTransposaseautoreactive T cellautoreactivitycentral tolerancehigh throughput analysislymphoid organnovel therapeuticsperipheral tolerancepreventreconstructionresponsesingle-cell RNA sequencingthymocytetranscriptome
项目摘要
In the thymus, central tolerance should eliminate the majority of immature T cells that
express autoreactive, pathogenic antigen receptors (αβTCRs). However, an unknown number of
autoreactive cells escape deletion or commit to immunosuppressive, regulatory linage (Tregs).
Tregs control peripheral tolerance and sustain dormancy of potentially autoreactive T cells.
However, mice and humans with disabled Tregs rapidly develop multiorgan autoimmunity and die
young, manifesting polyclonal activation of almost all CD4+ clones. Thus, we hypothesized that
the number of autoreactive clones embedded in the peripheral repertoire can be much higher (i.e.
over one-third of all CD4+ cells) as compared to what is currently anticipated. In Specific Aim 1,
we will examine how the intrathymic expression of different self-peptides supports or prevents an
escape of autoreactive T cells from central tolerance. This approach will document that potentially
self-reactive CD4+ clones commonly trespass to lymphoid organs of B6 mice as quiescent cells.
Next, we will test these cells ex vivo responses to a known set of self-peptides naturally presented
by mouse Ab molecules to determine if these clones are triggered by ubiquitous or specific
autoantigens. In Specific Aim 2, we will investigate why mice expressing single autoantigen
across the body have main autoimmunity manifestation in specific organs and examine the role
of non-classical CD4+ T cells in autoimmunity in this model. In Aim 3 we will use a new single-cell
RNA seq system from 10X Genomics, to examine in individual CD4+ cells their transcriptomes
and native αβTCRs to identify genes targeted by Tregs in potentially autoreactive cells to keep
them dormant and prevent autoimmunity. Overall, this application will revisit the relative
importance of various mechanisms of tolerance in the maintenance of homeostasis to self-
antigens and can reveal new mechanisms of how Tregs control self-reactivity.
在胸腺中,中枢耐受应该会消除大部分未成熟的T细胞
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
                item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:{{ item.author }} 
数据更新时间:{{ patent.updateTime }}
LESZEK IGNATOWICZ其他文献
LESZEK IGNATOWICZ的其他文献
{{
              item.title }}
{{ item.translation_title }}
- DOI:{{ item.doi }} 
- 发表时间:{{ item.publish_year }} 
- 期刊:
- 影响因子:{{ item.factor }}
- 作者:{{ item.authors }} 
- 通讯作者:{{ item.author }} 
{{ truncateString('LESZEK IGNATOWICZ', 18)}}的其他基金
Microbiome and immunosenescence of  T cells repertoire
T 细胞库的微生物组和免疫衰老
- 批准号:10661505 
- 财政年份:2020
- 资助金额:$ 38.99万 
- 项目类别:
Autoreactive CD4 T cells in healthy mice
健康小鼠的自身反应性 CD4 T 细胞
- 批准号:10621383 
- 财政年份:2020
- 资助金额:$ 38.99万 
- 项目类别:
Microbiome and immunosenescence of  T cells repertoire
T 细胞库的微生物组和免疫衰老
- 批准号:10417234 
- 财政年份:2020
- 资助金额:$ 38.99万 
- 项目类别:
Microbiome and immunosenescence of T cells repertoire
微生物组和 T 细胞库的免疫衰老
- 批准号:10259681 
- 财政年份:2020
- 资助金额:$ 38.99万 
- 项目类别:
Autoreactive CD4 T cells in healthy mice
健康小鼠的自身反应性 CD4 T 细胞
- 批准号:10404633 
- 财政年份:2020
- 资助金额:$ 38.99万 
- 项目类别:
Diversity of intraepithelial CD8aa T cells that recognize antignes from commensal flora
识别共生菌群抗原的上皮内 CD8aa T 细胞的多样性
- 批准号:9413085 
- 财政年份:2017
- 资助金额:$ 38.99万 
- 项目类别:
Antigenic specificities of intestinal CD4+Foxp3+ T cells.
肠道 CD4 Foxp3 T 细胞的抗原特异性。
- 批准号:9006761 
- 财政年份:2015
- 资助金额:$ 38.99万 
- 项目类别:
Role of CD4+T cells in maintenance of intestinal homeostasis
CD4 T 细胞在维持肠道稳态中的作用
- 批准号:8819131 
- 财政年份:2014
- 资助金额:$ 38.99万 
- 项目类别:
Role of CD4+T cells in maintenance of intestinal homeostasis
CD4 T 细胞在维持肠道稳态中的作用
- 批准号:9464232 
- 财政年份:2014
- 资助金额:$ 38.99万 
- 项目类别:
Role of CD4+T cells in maintenance of intestinal homeostasis
CD4 T 细胞在维持肠道稳态中的作用
- 批准号:8697992 
- 财政年份:2014
- 资助金额:$ 38.99万 
- 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:24K12256 
- 财政年份:2024
- 资助金额:$ 38.99万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:24K19176 
- 财政年份:2024
- 资助金额:$ 38.99万 
- 项目类别:Grant-in-Aid for Early-Career Scientists 
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:10578068 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:10933287 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:10650593 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:10649275 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:10784209 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:10734158 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:10580259 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:23K05057 
- 财政年份:2023
- 资助金额:$ 38.99万 
- 项目类别:Grant-in-Aid for Scientific Research (C) 

 刷新
              刷新
            
















 {{item.name}}会员
              {{item.name}}会员
            



